Catalyst
Slingshot members are tracking this event:
Data from Etrasimod Optimized Activity SIP Receptor Modulator in Treating Ulcerative Colitis expected Q4 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARNA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 10, 2017
Occurred Source:
http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=1048302
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Etrasimod, Sip Receptor Modulator, Ulcerative Colitis
